Ahn H - Search Results

1

Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter].

Lyu YS, Ahn H, Hong S, Park CY. Lyu YS, et al. Among authors: ahn h. Drug Des Devel Ther. 2025 Jan 6;19:65-66. doi: 10.2147/DDDT.S512114. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 39803608 Free PMC article. No abstract available.

2

Safety and Effectiveness of Naltrexone-Bupropion in Korean Adults with Obesity: Post-Marketing Surveillance Study.

Lyu YS, Ahn H, Hong S, Park CY. Lyu YS, et al. Among authors: ahn h. Drug Des Devel Ther. 2024 Nov 19;18:5255-5268. doi: 10.2147/DDDT.S492913. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 39583631 Free PMC article.

3

Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus.

Kim KS, Hong S, Ahn HY, Park CY. Kim KS, et al. Diabetes Ther. 2021 Jan;12(1):171-181. doi: 10.1007/s13300-020-00948-1. Epub 2020 Oct 24. Diabetes Ther. 2021. PMID: 33099742 Free PMC article.

4

Triglyceride and glucose index is a simple and easy-to-calculate marker associated with nonalcoholic fatty liver disease.

Kim KS, Hong S, Ahn HY, Park CY. Kim KS, et al. Obesity (Silver Spring). 2022 Jun;30(6):1279-1288. doi: 10.1002/oby.23438. Obesity (Silver Spring). 2022. PMID: 35674697

5

Evaluating Triglyceride and Glucose Index as a Simple and Easy-to-Calculate Marker for All-Cause and Cardiovascular Mortality.

Kim KS, Hong S, Hwang YC, Ahn HY, Park CY. Kim KS, et al. J Gen Intern Med. 2022 Dec;37(16):4153-4159. doi: 10.1007/s11606-022-07681-4. Epub 2022 Jun 8. J Gen Intern Med. 2022. PMID: 35676587 Free PMC article.

6

Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study.

Kim KS, Hong S, Ahn HY, Park CY. Kim KS, et al. Diabetes Metab J. 2023 Mar;47(2):220-231. doi: 10.4093/dmj.2021.0327. Epub 2023 Jan 12. Diabetes Metab J. 2023. PMID: 36631994 Free PMC article.

7

Prediction of future development of cardiovascular disease with an equation to estimate apolipoprotein B: A community-based cohort study.

Hwang YC, Park CY, Ahn HY, Cho NH. Hwang YC, et al. Among authors: ahn hy. Medicine (Baltimore). 2016 Jun;95(24):e3644. doi: 10.1097/MD.0000000000003644. Medicine (Baltimore). 2016. PMID: 27310947 Free PMC article.

8

Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study.

Hwang YC, Ahn HY, Han KH, Park SW, Park CY. Hwang YC, et al. Lipids Health Dis. 2017 Aug 22;16(1):158. doi: 10.1186/s12944-017-0549-8. Lipids Health Dis. 2017. PMID: 28830468 Free PMC article.

9

Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men.

Hwang YC, Ahn HY, Park SW, Park CY. Hwang YC, et al. Clin Gastroenterol Hepatol. 2018 Jul;16(7):1131-1137.e5. doi: 10.1016/j.cgh.2017.11.026. Epub 2017 Nov 20. Clin Gastroenterol Hepatol. 2018. PMID: 29158157

10

Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study.

Hwang YC, Ahn HY, Park CY. Hwang YC, et al. Obesity (Silver Spring). 2019 Aug;27(8):1360-1366. doi: 10.1002/oby.22536. Epub 2019 Jun 27. Obesity (Silver Spring). 2019. PMID: 31245932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,931 results

Search Page

Filters